 | XTL Biopharmaceuticals Ltd. | |||
| NCM : XTLB || Location: Israel | ||||
$2.56-0.03 (-1.16%) |
0.03 M | 2.45 - 2.58 | ||
| Last Updated:America/New_York | Volume | Day range |
Short Interest
| Short Date | Short Interest |
|---|---|
| March 28, 2024 | 0.437 M |
| March 15, 2024 | 0.002 M |
| Feb. 29, 2024 | 0.002 M |
| Feb. 15, 2024 | 0.003 M |
| Jan. 31, 2024 | 0.007 M |
EPS Surprise
| Period | Estimate | Actual | Surprise |
|---|---|---|---|
| 03/31/2016 | 0.00 | -0.01 | -1.00% |
| 12/31/2015 | 0.00 | -0.04 | -4.00% |
| 06/30/2015 | 0.00 | -0.10 | -10.00% |
| 03/31/2015 | 0.00 | -0.50 | -50.00% |
XTLB Basic Data
| Sector | Healthcare | Industry | Biotechnology |
| Shares Outstanding | 5.449M | Shares Float | 5.449M |
| Short Float | 0.437M | Market Cap | 14.11M |
| Institution ownership | 4.55% | Insider ownership | 0.000% |
| Earnings Date | Cash Per Share | ? | |
| Trailing EPS | -0.40 | Forward EPS | 0.00 |